For the study, published in the journal JAMA, the team looked at 398 non-asthmatic adults with acute chest infections -- but no evidence of pneumonia and not requiring immediate antibiotic treatment -- who were randomly split into two groups, one receiving 40 mg of the oral steroid "prednisolone" for five days and one receiving a placebo over the same time period.